Columns The MS Wire - A Column by Ed Tobias Why We Still Need to Wear Masks, Socially Distance, and Wash Our Hands Why We Still Need to Wear Masks, Socially Distance, and Wash Our Hands by Ed Tobias | April 2, 2021 Share this article: Share article via email Copy article link “I’ve had my shots, so I’m protected,” a friend recently told me, referring to the COVID-19 vaccine.Ā My wife and I also have received our COVID-19 vaccines. More than a month has passed since our second shots of the Moderna vaccine, so we are protected ā theoretically. But theory doesn’t always match reality, and I’ve been searching for a way to explain to people why we still wear our masks, keep our distance, and try to be good about washing our hands. It’s like being in the rain I found the explanation I’ve sought in an excellent article in The Atlantic by Katherine J. Wu, who likens protecting oneself from the coronavirus to trying to stay dry in a rainstorm: “Vaccination is actually more like a single variable in a dynamic playing fieldāa layer of protection, like an umbrella, that might guard better in some situations than others. It could keep a lucky traveler relatively dry in a light drizzle, but in a windy maelstrom thatās whipping heavy droplets every which way, another person might be overwhelmed. And under many circumstances, vaccines are still best paired with safeguards such as masks and distancingājust as rain boots and jackets would help buffer someone in a storm.“ The experts Wu interviewed suggest we curb our enthusiasm about the COVID-19 vaccine, no matter which version we’ve received. Like with seasonal flu vaccines, some people may be protected better than others. And like the way the seasonal flu changes its form from season to season, the SARS-CoV-2 coronavirus mutates as it moves between people. How does this happen? The news site Stat shared a great explanation with a video about how the virus changes. Of particular interest to people with MS being treated with a disease-modifying therapy (DMT) is that the COVID-19 vaccines generate antibodies and B- and T-cells that attack the coronavirus. But some of our DMTs ā notably, Ocrevus (ocrelizumab), Lemtrada (alemtuzumab), and Novantrone (mitoxantrone for injection concentrate) ā do the opposite. They’re designed to significantly reduce many of those T- or B-cells to prevent them from attacking our nervous system. So, the COVID-19 vaccines may limit the effectiveness of these DMTs for a period of time. It’s sort of a treatment Catch-22. What should you do? You can read the latest recommendations for DMTs and COVID-19 vaccines here. The information is updated frequently, though, and varies by country, so it’s best to check regularly. It’s also a conversation you should have with your neurologist. Not all neurologists think alike regarding the COVID-19 vaccines, so do your own research before that chat, and don’t be afraid to ask questions. Writing them down beforehand is always a good idea. Back to basics Vaccine or no vaccine, please continue to wear a mask, socially distance, and wash your hands. As the iconic New York Yankee Yogi Berra put it, “It ain’t over ’til it’s over.” You’re invited to visit my personal blog at www.themswire.com. *** Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, BioNews, and are intended to spark discussion about issues pertaining to multiple sclerosis. Print This Page About the Author Ed Tobias People say to write what you know and Ed Tobias knows about MS. He's lived with the illness since 1980, when he was 32 years old. Ed's a retired, award-winning broadcast journalist and his column combines his four decades of MS experiences with news and comments about the latest in the MS community. In addition to writing his column, Ed is one of the patient moderators on the MS News Today Facebook, Twitter, and Instagram sites. Heās also the author of āThe Multiple Sclerosis Toolbox: Hints and Tips for Living with M.S.ā Ed and his wife split their time between the Washington, D.C. suburbs and Floridaās Gulf Coast, trying to follow the sun. Tags COVID-19, COVID-19 vaccines, DMTs Comments Phil How long? Reply Ed Tobias https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated.html Reply Leave a comment Fill in the required fields to post. Your email address will not be published. Your Name Your Email Your Comment Post Comment
April 18, 2024 News by Marisa Wexler, MS AAN 2024: Sustained myelin, nerve cell gains with long-term CNM-Au8
April 18, 2024 News by Lindsey Shapiro, PhD AAN 2024: Ocrevus benefits Black, Hispanic patients same as whites
April 17, 2024 News by Marisa Wexler, MS AAN 2024: Fertility treatment in MS doesn’t increase relapse risk